word,tfidf
investigator,0.40860746864712066
sponsor,0.2575316715343405
sae,0.24781349525002574
participant,0.22365882494368708
pregnancy,0.21752240844145299
department,0.19258353358829278
adverse,0.16676110379845924
report,0.1627488802408871
documents,0.1621026865455414
follow,0.14452628995866468
reports,0.14270578388197236
data,0.13768480877718942
event,0.13682962362950502
crf,0.13005284766735453
safety,0.12742258700497655
email,0.12523607553152658
treatment,0.10347740286981315
initial,0.10000130153732165
reason,0.09698451331784529
subject,0.08999055730966699
information,0.08808407021149385
aphp,0.08728606198606076
possible,0.08494734216611192
fr,0.08312958284386739
sent,0.08035859674907181
participation,0.08035859674907181
consent,0.07945974741172722
state,0.0668124619546638
french,0.06559225154598516
file,0.06511817322769613
assessment,0.06328370092864606
complete,0.06157333063327725
additional,0.060718145485592845
methodology,0.059406856341878
participants,0.05914055467260956
hospital,0.05839812761584772
monitored,0.058309057705888415
medical,0.05815259004253963
signed,0.05709428567034907
following,0.05558703459948641
protection,0.05483942342369251
reference,0.05265404948969876
written,0.0522351975281917
resolved,0.051378902782164754
week,0.050739356780982445
inclusion,0.049600738565695565
centers,0.04849225665892264
84,0.04816772135827946
lost,0.04710676361152485
center,0.046237160925858396
reasons,0.046237160925858396
outcome,0.04532481282727353
kg,0.044469627679589126
woman,0.04433577751672927
amended,0.04335094922245151
collected,0.04308058594611717
emergency,0.04295028446933148
personal,0.04295028446933148
criteria,0.04212323959175901
analysis,0.0419040722365359
soon,0.04174535851050887
99,0.04174535851050887
collecting,0.04174535851050887
pregnant,0.04156479142193369
reaction,0.041302249208337624
provide,0.04086074686471207
termination,0.040179298374535904
44,0.040179298374535904
igg,0.040179298374535904
requests,0.04013976779856621
schedule,0.04008747717279828
reporting,0.04008747717279828
transplant,0.039338516793482686
relating,0.038793805327138116
initials,0.038534177086623565
centres,0.038534177086623565
procedure,0.03762814649811388
arm,0.03762814649811388
source,0.037336507819968216
visit,0.037336507819968216
contacted,0.03692858637468092
monitor,0.03692858637468092
recruitment,0.03692858637468092
acronym,0.03692858637468092
disease,0.03677296135042947
discontinuation,0.03655961561579501
completed,0.0354218151112519
sponsors,0.03532299566273827
dr,0.03532299566273827
carry,0.03532299566273827
mr,0.03463732618494475
test,0.034207405907376254
mg,0.034207405907376254
terminated,0.03371740495079562
product,0.03333376717910721
useful,0.033251833137546954
001,0.033251833137546954
cases,0.032798844959562236
use,0.03254977604817742
exposure,0.03254977604817742
item,0.032111814238852975
list,0.031866340090149166
date,0.03164185046432303
withdrawal,0.03159242969381926
centre,0.03159242969381926
acceptable,0.03158407292402289
national,0.031183201554648682
considered,0.030786665316638626
care,0.030635083339461102
tc,0.030506223526910323
permanently,0.030480847042751374
ap,0.030480847042751374
tests,0.03036930088848355
left,0.03010791874241942
previous,0.02967773698510294
33,0.02967773698510294
hp,0.029095353995353585
level,0.029076295021269814
explicit,0.028900632814967676
sfgm,0.028900632814967676
drci,0.028900632814967676
et,0.02872039063074478
laboratory,0.02872039063074478
evaluation,0.02872039063074478
section,0.027957353117960885
addition,0.027957353117960885
17,0.027763044276386623
visits,0.027763044276386623
various,0.027709860947955797
congenital,0.027709860947955797
primary,0.027365924725901002
followed,0.027365924725901002
permission,0.027295042103025025
processing,0.027295042103025025
effort,0.027295042103025025
attempts,0.027295042103025025
computer,0.027295042103025025
detailed,0.026882070305731625
included,0.02680569792202846
questions,0.02672498478186552
avoid,0.02672498478186552
events,0.026510739578216598
falls,0.026324367900558008
paris,0.0258483515676703
cnil,0.025689451391082377
network,0.025689451391082377
health,0.025655554430532187
general,0.02551021274632618
withdrawn,0.024938874853160216
monitoring,0.024891005213312143
10,0.024800369282847783
phase,0.024800369282847783
provided,0.024731504681273095
sign,0.024295440710786837
governing,0.02408386067913973
situations,0.02408386067913973
order,0.023945184135163375
appropriate,0.023933658858953984
hla,0.023933658858953984
randomized,0.023933658858953984
design,0.023656221869043828
examination,0.023656221869043828
agency,0.023553381805762424
regulation,0.023553381805762424
regulations,0.023553381805762424
father,0.023553381805762424
days,0.02308999898747897
comply,0.023080668675247495
accordance,0.023080668675247495
abnormality,0.023080668675247495
definition,0.023080668675247495
efficacy,0.022976312504595826
fully,0.022580939056814565
duplication,0.022478269967197078
cell,0.022234813839794563
randomization,0.022234813839794563
internal,0.022167888758364635
multicenter,0.022167888758364635
alive,0.022167888758364635
public,0.022167888758364635
msc,0.022018966150237667
european,0.021865896639708154
women,0.021865896639708154
saes,0.021865896639708154
forms,0.021865896639708154
enrolled,0.021505656244585298
specific,0.02137962869211016
function,0.021061619795879505
quickly,0.020872679255254434
intended,0.020872679255254434
unblinding,0.020872679255254434
preservation,0.020872679255254434
mondor,0.020872679255254434
make,0.020651124604168812
compliance,0.020651124604168812
end,0.02052444354442575
screening,0.020430373432356035
investigational,0.020430373432356035
implemented,0.020430373432356035
status,0.020104273441521346
required,0.020104273441521346
ii,0.019669258396741343
injection,0.019669258396741343
12,0.019669258396741343
death,0.019669258396741343
anti,0.019669258396741343
outpatient,0.01943635256862947
recruited,0.01943635256862947
examinations,0.01943635256862947
informed,0.019396902663569058
medicine,0.019355090620126768
biological,0.019355090620126768
discontinued,0.019355090620126768
receive,0.019355090620126768
determine,0.019355090620126768
ml,0.019355090620126768
tube,0.019267088543311783
scope,0.019267088543311783
obtain,0.019146927087163187
best,0.01881407324905694
procedures,0.018279807807897504
sample,0.018279807807897504
collect,0.018279807807897504
physical,0.01822158053309013
contact,0.01822158053309013
lack,0.01822158053309013
endpoint,0.01818958073280503
noted,0.01801140961617127
remains,0.01801140961617127
failed,0.01801140961617127
recruiting,0.01801140961617127
initially,0.01801140961617127
conducted,0.01801140961617127
secondary,0.01795888810137253
administration,0.01795888810137253
crfs,0.017661497831369135
baseline,0.01723223437844687
exposed,0.01723223437844687
signs,0.017103702953688127
weeks,0.017103702953688127
purpose,0.017006808497550787
open,0.016625916568773477
site,0.016625916568773477
participating,0.016625916568773477
identifying,0.016625916568773477
given,0.01627488802408871
total,0.01624851780600372
cells,0.01624851780600372
occurring,0.016129242183438974
saint,0.016129242183438974
law,0.016129242183438974
respond,0.016129242183438974
creteil,0.016055907119426487
commitment,0.016055907119426487
life,0.015393332658319313
risk,0.015393332658319313
30,0.015393332658319313
serum,0.015317541669730551
experimental,0.015317541669730551
ending,0.015240423521375687
particularly,0.015240423521375687
pi,0.015240423521375687
table,0.01505395937120971
identification,0.01505395937120971
lesion,0.014577264426472104
affect,0.014577264426472104
m0,0.014577264426472104
fertility,0.014577264426472104
departments,0.014450316407483838
board,0.014450316407483838
specify,0.014450316407483838
louis,0.01436019531537239
analyzed,0.013978676558980442
diseases,0.013978676558980442
childbearing,0.013854930473977898
2x106,0.013854930473977898
ecrf,0.013854930473977898
5mg,0.013854930473977898
period,0.013682962362950501
severe,0.013682962362950501
reported,0.013682962362950501
36,0.01340284896101423
pr,0.01340284896101423
investigators,0.01340284896101423
liver,0.01340284896101423
stage,0.01340284896101423
committee,0.01340284896101423
administered,0.01336249239093276
physician,0.01336249239093276
ebv,0.012903393746751179
consult,0.012844725695541188
salpetriere,0.012844725695541188
hospitals,0.012844725695541188
henri,0.012844725695541188
pitie,0.012844725695541188
hematology,0.012844725695541188
group,0.012827777215266093
placebo,0.012827777215266093
france,0.012827777215266093
donor,0.012827777215266093
capmatinib,0.012827777215266093
hepatitis,0.012469437426580108
hiv,0.012469437426580108
local,0.012469437426580108
multi,0.012469437426580108
skin,0.012445502606656072
48,0.012445502606656072
forced,0.012147720355393419
tubes,0.012147720355393419
atg,0.012147720355393419
ventricular,0.012147720355393419
exclusion,0.012147720355393419
methods,0.012147720355393419
20,0.011972592067581687
chimerism,0.011972592067581687
plasma,0.011972592067581687
count,0.011972592067581687
pre,0.011972592067581687
samples,0.011972592067581687
described,0.011828110934521914
enrolment,0.011828110934521914
history,0.011828110934521914
antibodies,0.011488156252297913
infectious,0.011488156252297913
tumor,0.011488156252297913
ratio,0.011488156252297913
specified,0.011488156252297913
prednisone,0.011488156252297913
uveitis,0.011488156252297913
anonymized,0.011239134983598539
copy,0.011239134983598539
collection,0.011117406919897281
reviewed,0.011083944379182318
oncology,0.011083944379182318
rheumatology,0.011083944379182318
sperm,0.011083944379182318
referred,0.011083944379182318
electrolytes,0.011083944379182318
sirolimus,0.011083944379182318
carried,0.010932948319854077
volume,0.010932948319854077
protein,0.010932948319854077
nb,0.010932948319854077
corresponding,0.010932948319854077
medication,0.010932948319854077
validate,0.010932948319854077
stated,0.010932948319854077
medicinal,0.010932948319854077
cycle,0.010752828122292649
expected,0.010752828122292649
vital,0.010752828122292649
hours,0.010752828122292649
identified,0.010752828122292649
age,0.010752828122292649
endpoints,0.010530809897939752
different,0.010530809897939752
levels,0.010262221772212875
toxicity,0.010262221772212875
response,0.010262221772212875
second,0.010262221772212875
groups,0.010262221772212875
treated,0.010262221772212875
special,0.009718176284314735
storage,0.009718176284314735
antigen,0.009718176284314735
controlled,0.009718176284314735
bayesian,0.009718176284314735
scan,0.009718176284314735
diagnosis,0.009718176284314735
circulating,0.009718176284314735
eligible,0.009718176284314735
comorbidities,0.009698451331784529
article,0.009698451331784529
serology,0.009698451331784529
typing,0.009698451331784529
tb,0.009698451331784529
situation,0.009698451331784529
reactions,0.009698451331784529
project,0.009698451331784529
200,0.009698451331784529
electrophoresis,0.009698451331784529
creatinine,0.009677545310063384
regimen,0.009677545310063384
m3,0.009677545310063384
106,0.009677545310063384
22,0.009677545310063384
final,0.009677545310063384
biopsy,0.009677545310063384
pulmonary,0.009677545310063384
figure,0.009633544271655891
consultation,0.009633544271655891
csm,0.009633544271655891
multicentre,0.009633544271655891
problem,0.009633544271655891
created,0.009633544271655891
likely,0.009633544271655891
edta,0.009633544271655891
doctor,0.009633544271655891
pharmacokinetic,0.009633544271655891
argenteuil,0.009633544271655891
assessments,0.009633544271655891
size,0.009573463543581594
allow,0.009573463543581594
appendix,0.009573463543581594
single,0.009573463543581594
met,0.00940703662452847
ongoing,0.00940703662452847
potential,0.00940703662452847
hsct,0.00940703662452847
usual,0.008616117189223435
receiving,0.008616117189223435
course,0.008616117189223435
covid,0.008616117189223435
16,0.008616117189223435
month,0.008616117189223435
shown,0.008602262497834119
weight,0.008602262497834119
flare,0.008602262497834119
05,0.008602262497834119
maximum,0.008602262497834119
01,0.008602262497834119
oral,0.008602262497834119
arms,0.008602262497834119
charge,0.008602262497834119
stopping,0.008602262497834119
duration,0.008551851476844063
early,0.008551851476844063
24,0.008551851476844063
associated,0.008551851476844063
pt,0.008503404248775394
dosage,0.008503404248775394
fixed,0.008503404248775394
participate,0.008503404248775394
area,0.008503404248775394
sampling,0.008503404248775394
conditions,0.008503404248775394
intravenous,0.008503404248775394
cohort,0.008503404248775394
suspected,0.008312958284386739
ovarian,0.008312958284386739
transmitted,0.008312958284386739
glucose,0.008312958284386739
apply,0.008312958284386739
htlv,0.008312958284386739
gt,0.008312958284386739
application,0.008312958284386739
rare,0.008312958284386739
ecog,0.008312958284386739
dry,0.008312958284386739
stable,0.008312958284386739
units,0.008312958284386739
telephone,0.008312958284386739
nature,0.008312958284386739
rennes,0.008312958284386739
code,0.008312958284386739
bichat,0.008027953559713244
presents,0.008027953559713244
75010,0.008027953559713244
mmr,0.008027953559713244
representative,0.008027953559713244
q3w,0.008027953559713244
competent,0.008027953559713244
amazzough,0.008027953559713244
modalities,0.008027953559713244
technique,0.008027953559713244
relevant,0.008027953559713244
annexe,0.008027953559713244
archival,0.008027953559713244
parallel,0.008027953559713244
recherche,0.008027953559713244
calcium,0.008027953559713244
develops,0.008027953559713244
quality,0.007696666329159657
19,0.007696666329159657
conditioning,0.007696666329159657
place,0.0076587708348652755
body,0.0076587708348652755
viral,0.0076587708348652755
hospitalization,0.0076587708348652755
cancer,0.0076587708348652755
infusion,0.0076587708348652755
regulatory,0.0076587708348652755
score,0.0076587708348652755
proposed,0.007526979685604855
gamma,0.007526979685604855
imaging,0.007526979685604855
recipient,0.007526979685604855
practice,0.007526979685604855
hgf,0.007526979685604855
team,0.007526979685604855
hemoglobin,0.007288632213236052
400,0.007288632213236052
scd,0.007288632213236052
necessary,0.007288632213236052
sante,0.007288632213236052
replaced,0.007288632213236052
doppler,0.007288632213236052
planned,0.007288632213236052
phosphatase,0.007288632213236052
investigating,0.007288632213236052
capacity,0.007288632213236052
la,0.007288632213236052
does,0.007288632213236052
hsv,0.007288632213236052
ejection,0.007288632213236052
recently,0.007288632213236052
stopped,0.007288632213236052
subcutaneously,0.007288632213236052
essential,0.007288632213236052
men,0.007288632213236052
conduct,0.007288632213236052
alkaline,0.007288632213236052
markers,0.007288632213236052
urine,0.007288632213236052
ferritin,0.007288632213236052
cmv,0.007288632213236052
condition,0.007288632213236052
serologies,0.006927465236988949
contained,0.006927465236988949
cardiovascular,0.006927465236988949
inhibitors,0.006927465236988949
interruption,0.006927465236988949
anonymous,0.006927465236988949
fev1,0.006927465236988949
fatal,0.006927465236988949
physicians,0.006927465236988949
truncation,0.006927465236988949
propose,0.006927465236988949
gastrectomy,0.006927465236988949
guidelines,0.006927465236988949
transaminases,0.006927465236988949
coordinating,0.006927465236988949
record,0.006927465236988949
summary,0.006927465236988949
ultrasound,0.006927465236988949
scheme,0.006927465236988949
hydroxyurea,0.006927465236988949
post,0.006841481181475251
40,0.006841481181475251
rate,0.006841481181475251
year,0.006841481181475251
transplantation,0.006841481181475251
management,0.006841481181475251
50,0.006841481181475251
adult,0.006701424480507115
allogeneic,0.006701424480507115
m2,0.006701424480507115
frequency,0.006701424480507115
concerning,0.006701424480507115
partial,0.006701424480507115
spartalizumab,0.006701424480507115
ssc,0.006701424480507115
occurrence,0.006701424480507115
18,0.006701424480507115
long,0.006701424480507115
25,0.006701424480507115
involving,0.0064516968733755896
complementary,0.0064516968733755896
renal,0.0064516968733755896
autoimmune,0.0064516968733755896
pcr,0.0064516968733755896
expression,0.0064516968733755896
comparing,0.0064516968733755896
accuracy,0.006422362847770594
cf,0.006422362847770594
fernand,0.006422362847770594
luminex,0.006422362847770594
obesity,0.006422362847770594
professional,0.006422362847770594
bilirubine,0.006422362847770594
29,0.006422362847770594
predictive,0.006422362847770594
height,0.006422362847770594
groupe,0.006422362847770594
working,0.006422362847770594
weekly,0.006422362847770594
compatibility,0.006422362847770594
stimulation,0.006422362847770594
cellulaire,0.006422362847770594
richerand,0.006422362847770594
request,0.006422362847770594
widal,0.006422362847770594
technology,0.006422362847770594
tel,0.006422362847770594
verification,0.006422362847770594
therapie,0.006422362847770594
investigations,0.006422362847770594
dsa,0.006422362847770594
asked,0.006422362847770594
office,0.006422362847770594
cover,0.006422362847770594
multicentric,0.006422362847770594
questionnaire,0.006073860177696709
pediatric,0.006073860177696709
pd,0.006073860177696709
paper,0.006073860177696709
35,0.006073860177696709
clinic,0.006073860177696709
fvc,0.006073860177696709
stratified,0.006073860177696709
min,0.006073860177696709
13,0.006073860177696709
ct,0.006073860177696709
tissue,0.006073860177696709
action,0.006073860177696709
pharmacokinetics,0.006073860177696709
persons,0.006073860177696709
sequential,0.006073860177696709
panel,0.006073860177696709
intravenously,0.006073860177696709
label,0.006073860177696709
cross,0.006073860177696709
60,0.005986296033790844
observed,0.005986296033790844
failure,0.005986296033790844
severity,0.005986296033790844
probability,0.005986296033790844
corticosteroid,0.005986296033790844
assessed,0.005986296033790844
behcets,0.005986296033790844
systemic,0.005986296033790844
high,0.005986296033790844
marrow,0.005744078126148956
sites,0.005744078126148956
symptoms,0.005744078126148956
factors,0.005744078126148956
selection,0.005744078126148956
significant,0.005744078126148956
belimumab,0.005744078126148956
adalimumab,0.005744078126148956
requiring,0.005744078126148956
injected,0.005744078126148956
parameters,0.005744078126148956
recommended,0.005744078126148956
unit,0.005744078126148956
neutrophil,0.005744078126148956
cycles,0.005744078126148956
threatening,0.005744078126148956
bias,0.005541972189591159
aspiration,0.005541972189591159
hematocrit,0.005541972189591159
contraception,0.005541972189591159
smpc,0.005541972189591159
ptt,0.005541972189591159
takes,0.005541972189591159
containing,0.005541972189591159
occur,0.005541972189591159
standardized,0.005541972189591159
dyslipidemia,0.005541972189591159
intention,0.005541972189591159
sectional,0.005541972189591159
orr,0.005541972189591159
immediately,0.005541972189591159
individual,0.005541972189591159
latest,0.005541972189591159
discontinue,0.005541972189591159
mentioned,0.005541972189591159
alemtuzumab,0.005541972189591159
delay,0.005541972189591159
centralized,0.005541972189591159
magnesium,0.005541972189591159
feasibility,0.005541972189591159
prothrombin,0.005541972189591159
determined,0.0053764140611463245
choice,0.0053764140611463245
measurement,0.0053764140611463245
replacement,0.0053764140611463245
values,0.0053764140611463245
surface,0.0053764140611463245
cov,0.0053764140611463245
versus,0.0053764140611463245
genetic,0.0053764140611463245
rapidly,0.0053764140611463245
biomedical,0.0053764140611463245
sibling,0.0053764140611463245
especially,0.0053764140611463245
search,0.0053764140611463245
abo,0.0053764140611463245
continue,0.0053764140611463245
crp,0.0053764140611463245
measures,0.005131110886106438
therapy,0.005131110886106438
active,0.005131110886106438
benefit,0.005131110886106438
sars,0.005131110886106438
gvhd,0.005131110886106438
grade,0.005131110886106438
check,0.004859088142157368
blind,0.004859088142157368
inactive,0.004859088142157368
myeloid,0.004859088142157368
inference,0.004859088142157368
checkpoint,0.004859088142157368
important,0.004859088142157368
shall,0.004859088142157368
w12,0.004859088142157368
arterial,0.004859088142157368
thrombocytopenia,0.004859088142157368
intervention,0.004859088142157368
rules,0.004859088142157368
neutropenia,0.004859088142157368
discretion,0.004859088142157368
digestive,0.004859088142157368
depending,0.004859088142157368
l1,0.004859088142157368
adherence,0.004859088142157368
determination,0.004859088142157368
maintain,0.004859088142157368
male,0.004859088142157368
frozen,0.004859088142157368
w8,0.004859088142157368
extension,0.004859088142157368
atlg,0.004859088142157368
hospitalisation,0.004859088142157368
combination,0.004859088142157368
sf,0.004859088142157368
simons,0.004859088142157368
26,0.004816772135827946
writing,0.004816772135827946
fai2r,0.004816772135827946
residence,0.004816772135827946
cd3,0.004816772135827946
comprehensive,0.004816772135827946
confidentiality,0.004816772135827946
75011,0.004816772135827946
hospitalier,0.004816772135827946
tacrolimus,0.004816772135827946
practices,0.004816772135827946
ethics,0.004816772135827946
selected,0.004816772135827946
toulouse,0.004816772135827946
hdcy,0.004816772135827946
75017,0.004816772135827946
apart,0.004816772135827946
7ml,0.004816772135827946
peak,0.004816772135827946
paragraph,0.004816772135827946
7g,0.004816772135827946
referral,0.004816772135827946
inherited,0.004816772135827946
listed,0.004816772135827946
marzouk,0.004816772135827946
represented,0.004816772135827946
resulting,0.004816772135827946
requested,0.004816772135827946
members,0.004816772135827946
sampled,0.004816772135827946
addressed,0.004816772135827946
thymo,0.004816772135827946
causal,0.004816772135827946
ophthalmology,0.004816772135827946
200mg,0.004816772135827946
red,0.004786731771790797
free,0.004786731771790797
obtained,0.004786731771790797
reduction,0.004786731771790797
radiation,0.004786731771790797
anemia,0.004786731771790797
iii,0.004786731771790797
camostat,0.004786731771790797
counts,0.004786731771790797
pembrolizumab,0.004786731771790797
testing,0.004786731771790797
right,0.004786731771790797
onset,0.004786731771790797
compared,0.004786731771790797
adaptive,0.004301131248917059
m1,0.004301131248917059
respiratory,0.004301131248917059
aims,0.004301131248917059
responsible,0.004301131248917059
worsening,0.004301131248917059
treat,0.004301131248917059
analysed,0.004301131248917059
al,0.004301131248917059
disorders,0.004301131248917059
act,0.004301131248917059
developed,0.004301131248917059
bone,0.004301131248917059
entry,0.004301131248917059
blinded,0.004301131248917059
reduced,0.004301131248917059
mofetil,0.004301131248917059
mycophenolate,0.004301131248917059
recorded,0.004301131248917059
interim,0.004301131248917059
graall,0.004301131248917059
authority,0.004301131248917059
pfs,0.004301131248917059
fact,0.004301131248917059
pressure,0.004301131248917059
clearance,0.004301131248917059
300,0.004301131248917059
platelets,0.004301131248917059
niu,0.004301131248917059
grafalon,0.004301131248917059
aplastic,0.004301131248917059
association,0.004301131248917059
positive,0.004301131248917059
particular,0.004301131248917059
progression,0.004275925738422032
previously,0.004275925738422032
doses,0.004275925738422032
lesions,0.004275925738422032
vasculitis,0.004275925738422032
treatments,0.004275925738422032
way,0.004156479142193369
findings,0.004156479142193369
feeding,0.004156479142193369
urinary,0.004156479142193369
karyotype,0.004156479142193369
lariboisiere,0.004156479142193369
cap,0.004156479142193369
ambulatory,0.004156479142193369
protocols,0.004156479142193369
sufficient,0.004156479142193369
entire,0.004156479142193369
culture,0.004156479142193369
regarding,0.004156479142193369
needed,0.004156479142193369
address,0.004156479142193369
rna,0.004156479142193369
deficiency,0.004156479142193369
observation,0.004156479142193369
inclusions,0.004156479142193369
d0,0.004156479142193369
oedema,0.004156479142193369
80c,0.004156479142193369
copies,0.004156479142193369
contain,0.004156479142193369
healthy,0.004156479142193369
collaboration,0.004156479142193369
pharmacodynamic,0.004156479142193369
w1,0.004156479142193369
continued,0.004156479142193369
showed,0.004156479142193369
showing,0.004156479142193369
gastroenterology,0.004156479142193369
trsae,0.004156479142193369
prophylactic,0.004156479142193369
concentrations,0.004156479142193369
sickle,0.004156479142193369
review,0.0038293854174326378
confirmed,0.0038293854174326378
present,0.0038293854174326378
sle,0.0038293854174326378
population,0.0038293854174326378
considering,0.0038293854174326378
points,0.0038293854174326378
antibody,0.0038293854174326378
mean,0.0038293854174326378
absence,0.0038293854174326378
eligibility,0.0038293854174326378
medications,0.0038293854174326378
perform,0.0038293854174326378
graft,0.0038293854174326378
received,0.0038293854174326378
assess,0.0038293854174326378
identical,0.0038293854174326378
decrease,0.0038293854174326378
2013,0.0038293854174326378
kaposi,0.0038293854174326378
concomitant,0.0038293854174326378
taken,0.0038293854174326378
unless,0.003644316106618026
safe,0.003644316106618026
prescribed,0.003644316106618026
transmission,0.003644316106618026
rule,0.003644316106618026
large,0.003644316106618026
cd4,0.003644316106618026
carcinoma,0.003644316106618026
v3,0.003644316106618026
assigned,0.003644316106618026
outside,0.003644316106618026
inform,0.003644316106618026
glucocorticoids,0.003644316106618026
continuous,0.003644316106618026
half,0.003644316106618026
enrollment,0.003644316106618026
birth,0.003644316106618026
illness,0.003644316106618026
hydrocortisone,0.003644316106618026
identify,0.003644316106618026
des,0.003644316106618026
statistical,0.003644316106618026
ensuring,0.003644316106618026
detection,0.003644316106618026
cd19,0.003644316106618026
principal,0.003644316106618026
45,0.003644316106618026
fludrocortisone,0.003644316106618026
bilirubin,0.003644316106618026
2017,0.003644316106618026
binary,0.003644316106618026
dsmb,0.003644316106618026
later,0.003644316106618026
mscs,0.003644316106618026
stored,0.003644316106618026
immunosuppression,0.003644316106618026
breast,0.003644316106618026
relationship,0.003644316106618026
applied,0.003644316106618026
myeloablative,0.003644316106618026
w4,0.003644316106618026
macular,0.0034207405907376253
haplo,0.0034207405907376253
70,0.0034207405907376253
infection,0.0034207405907376253
immune,0.0034207405907376253
peripheral,0.0034207405907376253
optimal,0.0034207405907376253
cryoglobulinemia,0.0034207405907376253
recommendations,0.0034207405907376253
activity,0.0034207405907376253
iv,0.0034207405907376253
allowing,0.0032258484366877948
allows,0.0032258484366877948
concentration,0.0032258484366877948
relative,0.0032258484366877948
prophylaxis,0.0032258484366877948
mesylate,0.0032258484366877948
impact,0.0032258484366877948
hypertension,0.0032258484366877948
twice,0.0032258484366877948
immediate,0.0032258484366877948
thymoglobulin,0.0032258484366877948
recent,0.0032258484366877948
lymphocytes,0.0032258484366877948
lymphocyte,0.0032258484366877948
infliximab,0.0032258484366877948
consumption,0.0032258484366877948
responders,0.0032258484366877948
gene,0.0032258484366877948
donors,0.0032258484366877948
uncontrolled,0.0032258484366877948
transplanted,0.0032258484366877948
point,0.0032258484366877948
unacceptable,0.0032258484366877948
dna,0.0032258484366877948
individuals,0.0032258484366877948
analyses,0.0032258484366877948
cutaneous,0.0032258484366877948
letter,0.003211181423885297
universitaire,0.003211181423885297
consist,0.003211181423885297
flexibility,0.003211181423885297
pooled,0.003211181423885297
slow,0.003211181423885297
les,0.003211181423885297
retained,0.003211181423885297
unblinded,0.003211181423885297
systematically,0.003211181423885297
cleanweb,0.003211181423885297
sinus,0.003211181423885297
simplicity,0.003211181423885297
amh,0.003211181423885297
jean,0.003211181423885297
investigation,0.003211181423885297
cd56,0.003211181423885297
39,0.003211181423885297
randomised,0.003211181423885297
2mg,0.003211181423885297
30min,0.003211181423885297
w2,0.003211181423885297
examples,0.003211181423885297
gastric,0.003211181423885297
4ml,0.003211181423885297
tropical,0.003211181423885297
rct,0.003211181423885297
realize,0.003211181423885297
pfu,0.003211181423885297
measurements,0.003211181423885297
schedules,0.003211181423885297
recall,0.003211181423885297
clinique,0.003211181423885297
assistants,0.003211181423885297
characterized,0.003211181423885297
cd14,0.003211181423885297
hand,0.003211181423885297
archiving,0.003211181423885297
sex,0.003211181423885297
unite,0.003211181423885297
liquid,0.003211181423885297
paxgene,0.003211181423885297
evaluations,0.003211181423885297
ghsif,0.003211181423885297
unexposed,0.003211181423885297
maladies,0.003211181423885297
le,0.003211181423885297
volunteers,0.003211181423885297
w10,0.003211181423885297
paramedical,0.003211181423885297
sur,0.003211181423885297
surname,0.003211181423885297
cooperative,0.003211181423885297
cmax,0.003211181423885297
boundaries,0.003211181423885297
informations,0.003211181423885297
mathec,0.003211181423885297
sud,0.003211181423885297
gy,0.003211181423885297
occurred,0.003211181423885297
occupational,0.003211181423885297
techniques,0.003211181423885297
nuclear,0.003211181423885297
nct02795429,0.003211181423885297
registered,0.003211181423885297
ono,0.003211181423885297
enrollments,0.003211181423885297
ekg,0.003211181423885297
envelope,0.003211181423885297
offers,0.003211181423885297
ihc,0.003211181423885297
did,0.003211181423885297
notebook,0.003211181423885297
ile,0.003211181423885297
dates,0.003211181423885297
teleconsultation,0.003211181423885297
stress,0.003211181423885297
industrial,0.003211181423885297
melun,0.003211181423885297
melanoma,0.003211181423885297
1h,0.003211181423885297
justification,0.003211181423885297
knowing,0.003211181423885297
purposes,0.003211181423885297
puncture,0.003211181423885297
feature,0.003211181423885297
explorations,0.003211181423885297
programs,0.003211181423885297
w6,0.003211181423885297
approach,0.002872039063074478
release,0.002872039063074478
tocilizumab,0.002872039063074478
inhibitor,0.002872039063074478
cyclophosphamide,0.002872039063074478
ensure,0.002872039063074478
nk,0.002872039063074478
notably,0.002872039063074478
refer,0.002872039063074478
index,0.002872039063074478
heart,0.002872039063074478
infusions,0.002872039063074478
reduce,0.002872039063074478
evaluated,0.002872039063074478
uninjected,0.002872039063074478
corticosteroids,0.002872039063074478
characteristics,0.002872039063074478
matched,0.002872039063074478
central,0.002872039063074478
double,0.002872039063074478
loss,0.002872039063074478
good,0.002872039063074478
presence,0.002872039063074478
follows,0.002872039063074478
provides,0.0027709860947955794
young,0.0027709860947955794
uc,0.0027709860947955794
scientific,0.0027709860947955794
moment,0.0027709860947955794
proposal,0.0027709860947955794
condom,0.0027709860947955794
kept,0.0027709860947955794
worthy,0.0027709860947955794
field,0.0027709860947955794
hypersensitivity,0.0027709860947955794
igra,0.0027709860947955794
sealed,0.0027709860947955794
actually,0.0027709860947955794
vasoconstrictor,0.0027709860947955794
implies,0.0027709860947955794
submitted,0.0027709860947955794
subcutaneous,0.0027709860947955794
replete,0.0027709860947955794
cancers,0.0027709860947955794
subpopulations,0.0027709860947955794
tuberculosis,0.0027709860947955794
started,0.0027709860947955794
c2d1,0.0027709860947955794
nih,0.0027709860947955794
chu,0.0027709860947955794
requires,0.0027709860947955794
designs,0.0027709860947955794
stop,0.0027709860947955794
appendices,0.0027709860947955794
relapsing,0.0027709860947955794
adjudication,0.0027709860947955794
validity,0.0027709860947955794
concerns,0.0027709860947955794
isoniazid,0.0027709860947955794
27,0.0027709860947955794
1mg,0.0027709860947955794
compatible,0.0027709860947955794
w35,0.0027709860947955794
immunology,0.0027709860947955794
knowledge,0.0027709860947955794
involves,0.0027709860947955794
cpp,0.0027709860947955794
increasing,0.0027709860947955794
ancillary,0.0027709860947955794
saturation,0.0027709860947955794
electronic,0.0027709860947955794
indication,0.0027709860947955794
spermogram,0.0027709860947955794
obtaining,0.0027709860947955794
suggestive,0.0027709860947955794
head,0.0027709860947955794
small,0.0027709860947955794
healthcare,0.0027709860947955794
suggested,0.0027709860947955794
diaphragm,0.0027709860947955794
close,0.0027709860947955794
stabilization,0.0027709860947955794
performans,0.0027709860947955794
country,0.0027709860947955794
corresponds,0.0027709860947955794
cm,0.0027709860947955794
stages,0.0027709860947955794
participated,0.0027709860947955794
gp,0.0027709860947955794
hcg,0.0027709860947955794
vitro,0.0027709860947955794
contraceptive,0.0027709860947955794
partner,0.0027709860947955794
cream,0.0027709860947955794
cessation,0.0027709860947955794
malignancy,0.0027709860947955794
diameter,0.0027709860947955794
error,0.0027709860947955794
institute,0.0027709860947955794
allergic,0.0027709860947955794
m4,0.0027709860947955794
maintained,0.0027709860947955794
blocks,0.0027709860947955794
auto,0.0027709860947955794
rarely,0.0027709860947955794
planning,0.0027709860947955794
ray,0.0027709860947955794
supervision,0.0027709860947955794
device,0.0027709860947955794
disability,0.0027709860947955794
leading,0.0027709860947955794
avoiding,0.0027709860947955794
confirmation,0.0027709860947955794
consistent,0.0027709860947955794
situ,0.0027709860947955794
43,0.0027709860947955794
result,0.0027709860947955794
example,0.0027709860947955794
gel,0.0027709860947955794
pk,0.0027709860947955794
blinding,0.0027709860947955794
excessive,0.0027709860947955794
premedication,0.0027709860947955794
considers,0.0027709860947955794
20mg,0.0027709860947955794
signing,0.0027709860947955794
biobanking,0.0027709860947955794
betamethasone,0.0027709860947955794
investigated,0.0027709860947955794
donnees,0.0027709860947955794
evidence,0.002565555443053219
evolution,0.002565555443053219
available,0.002565555443053219
posterior,0.002565555443053219
sensitivity,0.002565555443053219
relapse,0.002565555443053219
multiple,0.002565555443053219
amplification,0.002565555443053219
refractory,0.002565555443053219
decision,0.002565555443053219
retinal,0.002565555443053219
ocular,0.002565555443053219
modified,0.002565555443053219
increase,0.002565555443053219
model,0.002565555443053219
resolution,0.002565555443053219
independent,0.002565555443053219
w24,0.002429544071078684
40mg,0.002429544071078684
products,0.002429544071078684
w20,0.002429544071078684
150,0.002429544071078684
extensive,0.002429544071078684
keytruda,0.002429544071078684
2005,0.002429544071078684
prospective,0.002429544071078684
proportions,0.002429544071078684
white,0.002429544071078684
epidemiology,0.002429544071078684
borr,0.002429544071078684
oxygen,0.002429544071078684
chest,0.002429544071078684
sedimentation,0.002429544071078684
haploidentical,0.002429544071078684
rbc,0.002429544071078684
documentation,0.002429544071078684
w16,0.002429544071078684
phenotyping,0.002429544071078684
prescription,0.002429544071078684
basis,0.002429544071078684
times,0.002429544071078684
attenuated,0.002429544071078684
leukemia,0.002429544071078684
eortc,0.002429544071078684
recurrence,0.002429544071078684
c30,0.002429544071078684
access,0.002429544071078684
du,0.002429544071078684
host,0.002429544071078684
assay,0.002429544071078684
deaths,0.002429544071078684
registry,0.002429544071078684
derived,0.002429544071078684
terminology,0.002429544071078684
echocardiography,0.002429544071078684
hepatic,0.002429544071078684
recipients,0.002429544071078684
auc,0.002429544071078684
objectives,0.002429544071078684
orally,0.002429544071078684
appears,0.002429544071078684
direct,0.002429544071078684
disorder,0.002429544071078684
diabetes,0.002429544071078684
mrd,0.002429544071078684
adenocarcinoma,0.002429544071078684
strong,0.002429544071078684
missing,0.002429544071078684
informative,0.002429544071078684
intervals,0.002429544071078684
description,0.002429544071078684
established,0.002429544071078684
died,0.002429544071078684
agreed,0.002429544071078684
agents,0.002429544071078684
scheduled,0.002429544071078684
mass,0.002429544071078684
charlson,0.002429544071078684
diagnosed,0.002429544071078684
malignancies,0.002429544071078684
intensity,0.002429544071078684
unique,0.002429544071078684
allocated,0.002429544071078684
magnetic,0.002429544071078684
resonance,0.002429544071078684
qlq,0.002429544071078684
comparative,0.002429544071078684
28,0.002429544071078684
range,0.002429544071078684
109,0.002429544071078684
w30,0.002429544071078684
w36,0.002429544071078684
target,0.0021505656244585297
w55,0.0021505656244585297
potentially,0.0021505656244585297
lung,0.0021505656244585297
profile,0.0021505656244585297
allo,0.0021505656244585297
beta,0.0021505656244585297
500,0.0021505656244585297
treosulfan,0.0021505656244585297
setting,0.0021505656244585297
common,0.0021505656244585297
fish,0.0021505656244585297
documented,0.0021505656244585297
role,0.0021505656244585297
ph,0.0021505656244585297
cohorts,0.0021505656244585297
coherence,0.0021505656244585297
80mg,0.0021505656244585297
voc,0.0021505656244585297
indexed,0.0021505656244585297
causes,0.0021505656244585297
optical,0.0021505656244585297
observations,0.0021505656244585297
currently,0.0021505656244585297
require,0.0021505656244585297
attributed,0.0021505656244585297
difference,0.0021505656244585297
immunogenicity,0.0021505656244585297
hopital,0.0021505656244585297
set,0.0021505656244585297
clinically,0.0021505656244585297
cr,0.0021505656244585297
scores,0.0021505656244585297
adequate,0.0021505656244585297
wbc,0.0021505656244585297
known,0.0021505656244585297
modification,0.0021505656244585297
directly,0.0021505656244585297
21,0.0021505656244585297
aml,0.0021505656244585297
acs,0.0021505656244585297
mri,0.0021505656244585297
human,0.0021505656244585297
occurs,0.0021505656244585297
decreased,0.0021505656244585297
intermediate,0.0021505656244585297
version,0.0021505656244585297
absolute,0.0021505656244585297
cytokine,0.0021505656244585297
ctcae,0.0021505656244585297
meet,0.0021505656244585297
injections,0.0021505656244585297
initiation,0.0021505656244585297
cumulative,0.0021505656244585297
nervous,0.0021505656244585297
negative,0.0021505656244585297
mud,0.0021505656244585297
method,0.0021505656244585297
respectively,0.0021505656244585297
platelet,0.0019146927087163189
55,0.0019146927087163189
inflammatory,0.0019146927087163189
antibiotic,0.0019146927087163189
factor,0.0019146927087163189
tolerance,0.0019146927087163189
80,0.0019146927087163189
inflammation,0.0019146927087163189
support,0.0019146927087163189
scale,0.0019146927087163189
having,0.0019146927087163189
sun,0.0019146927087163189
mds,0.0019146927087163189
stem,0.0019146927087163189
starting,0.0019146927087163189
residual,0.0019146927087163189
international,0.0019146927087163189
sparing,0.0019146927087163189
higher,0.0019146927087163189
change,0.0019146927087163189
outcomes,0.0019146927087163189
term,0.0019146927087163189
mortality,0.0019146927087163189
type,0.0019146927087163189
vascular,0.0019146927087163189
need,0.0019146927087163189
incidence,0.0019146927087163189
interaction,0.0019146927087163189
responses,0.0019146927087163189
comparison,0.0019146927087163189
delayed,0.0019146927087163189
sct,0.0019146927087163189
100,0.0019146927087163189
late,0.0019146927087163189
2012,0.0019146927087163189
ks,0.0019146927087163189
11,0.0019146927087163189
daily,0.0017103702953688126
tnf,0.0017103702953688126
remission,0.0017103702953688126
acute,0.0017103702953688126
complications,0.0017103702953688126
greater,0.0017103702953688126
syndrome,0.0017103702953688126
current,0.0017103702953688126
poor,0.0017103702953688126
involvement,0.0017103702953688126
main,0.0017103702953688126
value,0.0017103702953688126
eye,0.0017103702953688126
increased,0.0017103702953688126
infections,0.0017103702953688126
steroid,0.0017103702953688126
sections,0.0016055907119426486
haut,0.0016055907119426486
semi,0.0016055907119426486
6mg,0.0016055907119426486
diarrhea,0.0016055907119426486
institutions,0.0016055907119426486
spo2,0.0016055907119426486
causing,0.0016055907119426486
thirty,0.0016055907119426486
anticipate,0.0016055907119426486
wish,0.0016055907119426486
cedex,0.0016055907119426486
57,0.0016055907119426486
600mg,0.0016055907119426486
sm,0.0016055907119426486
traditional,0.0016055907119426486
225,0.0016055907119426486
23,0.0016055907119426486
jet,0.0016055907119426486
antral,0.0016055907119426486
johnson,0.0016055907119426486
route,0.0016055907119426486
routinely,0.0016055907119426486
rubi,0.0016055907119426486
run,0.0016055907119426486
intraveinously,0.0016055907119426486
invest,0.0016055907119426486
staggered,0.0016055907119426486
jh,0.0016055907119426486
corticotrophin,0.0016055907119426486
council,0.0016055907119426486
perfusion,0.0016055907119426486
parties,0.0016055907119426486
cut,0.0016055907119426486
cutanee,0.0016055907119426486
cps,0.0016055907119426486
crocchiolo,0.0016055907119426486
suspended,0.0016055907119426486
clinicians,0.0016055907119426486
realized,0.0016055907119426486
eot,0.0016055907119426486
separate,0.0016055907119426486
separated,0.0016055907119426486
boutboul,0.0016055907119426486
pathologic,0.0016055907119426486
owing,0.0016055907119426486
correspondence,0.0016055907119426486
wittes,0.0016055907119426486
respected,0.0016055907119426486
thymoglobuline,0.0016055907119426486
supplementary,0.0016055907119426486
continuation,0.0016055907119426486
contribute,0.0016055907119426486
pbsc,0.0016055907119426486
ped,0.0016055907119426486
corticoids,0.0016055907119426486
paediatric,0.0016055907119426486
paracetamol,0.0016055907119426486
vincent,0.0016055907119426486
87,0.0016055907119426486
8mg,0.0016055907119426486
gregory,0.0016055907119426486
georges,0.0016055907119426486
goes,0.0016055907119426486
topoisomerase,0.0016055907119426486
companies,0.0016055907119426486
pursuant,0.0016055907119426486
q4w,0.0016055907119426486
qql,0.0016055907119426486
qualified,0.0016055907119426486
benlysta,0.0016055907119426486
lacking,0.0016055907119426486
balance,0.0016055907119426486
justified,0.0016055907119426486
kt,0.0016055907119426486
productivity,0.0016055907119426486
forwarded,0.0016055907119426486
fraall2000,0.0016055907119426486
francais,0.0016055907119426486
prof,0.0016055907119426486
31,0.0016055907119426486
lan,0.0016055907119426486
practical,0.0016055907119426486
practitioners,0.0016055907119426486
predictor,0.0016055907119426486
inflation,0.0016055907119426486
maximal,0.0016055907119426486
making,0.0016055907119426486
alloantibodies,0.0016055907119426486
allocation,0.0016055907119426486
proton,0.0016055907119426486
managed,0.0016055907119426486
price,0.0016055907119426486
collects,0.0016055907119426486
binders,0.0016055907119426486
farge,0.0016055907119426486
tapering,0.0016055907119426486
faster,0.0016055907119426486
172,0.0016055907119426486
unemployment,0.0016055907119426486
sharma,0.0016055907119426486
gender,0.0016055907119426486
possibility,0.0016055907119426486
ranging,0.0016055907119426486
rares,0.0016055907119426486
coordinator,0.0016055907119426486
consists,0.0016055907119426486
consults,0.0016055907119426486
324,0.0016055907119426486
francois,0.0016055907119426486
follicle,0.0016055907119426486
seven,0.0016055907119426486
treg,0.0016055907119426486
tried,0.0016055907119426486
retinopathy,0.0016055907119426486
baltimore,0.0016055907119426486
baron,0.0016055907119426486
going,0.0016055907119426486
344,0.0016055907119426486
profiling,0.0016055907119426486
profound,0.0016055907119426486
bayes,0.0016055907119426486
behalf,0.0016055907119426486
bid,0.0016055907119426486
46,0.0016055907119426486
4mg,0.0016055907119426486
explain,0.0016055907119426486
biased,0.0016055907119426486
simulations,0.0016055907119426486
fetal,0.0016055907119426486
fictive,0.0016055907119426486
colorectal,0.0016055907119426486
consented,0.0016055907119426486
exhaustive,0.0016055907119426486
experiments,0.0016055907119426486
skins,0.0016055907119426486
cl,0.0016055907119426486
dermatology,0.0016055907119426486
database,0.0016055907119426486
multiplicity,0.0016055907119426486
muscles,0.0016055907119426486
ulcer,0.0016055907119426486
approval,0.0016055907119426486
advantage,0.0016055907119426486
ar,0.0016055907119426486
naive,0.0016055907119426486
nasopharyngeal,0.0016055907119426486
montpellier,0.0016055907119426486
living,0.0016055907119426486
dimension,0.0016055907119426486
discovered,0.0016055907119426486
disposition,0.0016055907119426486
aptt,0.0016055907119426486
efferocytosis,0.0016055907119426486
dosing,0.0016055907119426486
vd,0.0016055907119426486
acting,0.0016055907119426486
activities,0.0016055907119426486
acts,0.0016055907119426486
chronology,0.0016055907119426486
hypotension,0.0016055907119426486
chru,0.0016055907119426486
establish,0.0016055907119426486
devillier,0.0016055907119426486
leave,0.0016055907119426486
leclerc,0.0016055907119426486
hour,0.0016055907119426486
hyperthermia,0.0016055907119426486
tmax,0.0016055907119426486
bradycardia,0.0016055907119426486
identity,0.0016055907119426486
110,0.0016055907119426486
124,0.0016055907119426486
provisions,0.0016055907119426486
publication,0.0016055907119426486
promoter,0.0016055907119426486
protease,0.0016055907119426486
quarterly,0.0016055907119426486
filiere,0.0016055907119426486
modifications,0.0016055907119426486
work,0.0016055907119426486
consequences,0.0016055907119426486
ivanova,0.0016055907119426486
pump,0.0016055907119426486
pugnet,0.0016055907119426486
want,0.0016055907119426486
explanation,0.0016055907119426486
feasible,0.0016055907119426486
finished,0.0016055907119426486
modify,0.0016055907119426486
relies,0.0016055907119426486
removal,0.0016055907119426486
added,0.0016055907119426486
addenda,0.0016055907119426486
adipose,0.0016055907119426486
validation,0.0016055907119426486
immunomodulator,0.0016055907119426486
randomize,0.0016055907119426486
types,0.0016055907119426486
induce,0.0016055907119426486
valued,0.0016055907119426486
demets,0.0016055907119426486
proceed,0.0016055907119426486
tbi,0.0016055907119426486
compound,0.0016055907119426486
quasi,0.0016055907119426486
scl,0.0016055907119426486
hold,0.0016055907119426486
doesnt,0.0016055907119426486
dominique,0.0016055907119426486
driven,0.0016055907119426486
dsi,0.0016055907119426486
duplicate,0.0016055907119426486
distributed,0.0016055907119426486
animals,0.0016055907119426486
enclosed,0.0016055907119426486
leukocyte,0.0016055907119426486
restricted,0.0016055907119426486
retina,0.0016055907119426486
verify,0.0016055907119426486
decide,0.0016055907119426486
interventions,0.0016055907119426486
inr,0.0016055907119426486
unlikely,0.0016055907119426486
uncertainty,0.0016055907119426486
retrieved,0.0016055907119426486
eradicate,0.0016055907119426486
associations,0.0016055907119426486
kit,0.0016055907119426486
agreeing,0.0016055907119426486
representing,0.0016055907119426486
engagement,0.0016055907119426486
elimination,0.0016055907119426486
achievable,0.0016055907119426486
challenge,0.0016055907119426486
characteristic,0.0016055907119426486
cd34,0.0016055907119426486
opportunity,0.0016055907119426486
options,0.0016055907119426486
96,0.0016055907119426486
curve,0.0016055907119426486
accumulated,0.0016055907119426486
maria,0.0016055907119426486
subsequently,0.0016055907119426486
registration,0.0016055907119426486
regurgitant,0.0016055907119426486
hepatocellular,0.0016055907119426486
guideline,0.0016055907119426486
evolving,0.0016055907119426486
sofa,0.0016055907119426486
soluble,0.0016055907119426486
urc,0.0016055907119426486
necessarily,0.0016055907119426486
depend,0.0016055907119426486
microsatellite,0.0016055907119426486
inefficacious,0.0016055907119426486
immunes,0.0016055907119426486
mrt,0.0016055907119426486
modelling,0.0016055907119426486
ellenberg,0.0016055907119426486
rejected,0.0016055907119426486
lungs,0.0016055907119426486
lyon,0.0016055907119426486
rescue,0.0016055907119426486
v0,0.0016055907119426486
v2,0.0016055907119426486
defect,0.0016055907119426486
browser,0.0016055907119426486
cancerologie,0.0016055907119426486
cytopenias,0.0016055907119426486
suited,0.0016055907119426486
supervised,0.0016055907119426486
ad,0.0016055907119426486
hypofertility,0.0016055907119426486
hepatocyte,0.0016055907119426486
heterogeneity,0.0016055907119426486
cytof,0.0016055907119426486
cytogenetics,0.0016055907119426486
substantial,0.0016055907119426486
zone,0.0013854930473977897
1000,0.0013854930473977897
1121,0.0013854930473977897
1500,0.0013854930473977897
150mg,0.0013854930473977897
willingness,0.0013854930473977897
03,0.0013854930473977897
02,0.0013854930473977897
42,0.0013854930473977897
3mg,0.0013854930473977897
w13,0.0013854930473977897
vomiting,0.0013854930473977897
75,0.0013854930473977897
66,0.0013854930473977897
5ml,0.0013854930473977897
5d,0.0013854930473977897
56,0.0013854930473977897
94,0.0013854930473977897
rationale,0.0013854930473977897
phosphate,0.0013854930473977897
philadelphia,0.0013854930473977897
poorly,0.0013854930473977897
policy,0.0013854930473977897
preventing,0.0013854930473977897
91,0.0013854930473977897
7mg,0.0013854930473977897
75475,0.0013854930473977897
versions,0.0013854930473977897
verified,0.0013854930473977897
venous,0.0013854930473977897
accrual,0.0013854930473977897
accepted,0.0013854930473977897
abdominal,0.0013854930473977897
opioid,0.0013854930473977897
ovulation,0.0013854930473977897
past,0.0013854930473977897
partners,0.0013854930473977897
parity,0.0013854930473977897
performing,0.0013854930473977897
pbmc,0.0013854930473977897
actual,0.0013854930473977897
activated,0.0013854930473977897
velocity,0.0013854930473977897
vellefaux,0.0013854930473977897
variants,0.0013854930473977897
variables,0.0013854930473977897
adequately,0.0013854930473977897
affiliated,0.0013854930473977897
reducing,0.0013854930473977897
obrien,0.0013854930473977897
nursing,0.0013854930473977897
null,0.0013854930473977897
olivier,0.0013854930473977897
oestrogen,0.0013854930473977897
optional,0.0013854930473977897
opioids,0.0013854930473977897
administrated,0.0013854930473977897
v1,0.0013854930473977897
alloreactive,0.0013854930473977897
alat,0.0013854930473977897
analyse,0.0013854930473977897
amenorrhea,0.0013854930473977897
alternatively,0.0013854930473977897
nelarabine,0.0013854930473977897
necker,0.0013854930473977897
nausea,0.0013854930473977897
register,0.0013854930473977897
regional,0.0013854930473977897
refusal,0.0013854930473977897
noninfectious,0.0013854930473977897
undergo,0.0013854930473977897
ansm,0.0013854930473977897
anaphylactic,0.0013854930473977897
antiviral,0.0013854930473977897
antinuclear,0.0013854930473977897
antigens,0.0013854930473977897
anticoagulants,0.0013854930473977897
repair,0.0013854930473977897
mononeuropathy,0.0013854930473977897
monocytes,0.0013854930473977897
mos,0.0013854930473977897
n1,0.0013854930473977897
multidisciplinary,0.0013854930473977897
applies,0.0013854930473977897
applicable,0.0013854930473977897
unable,0.0013854930473977897
umbilical,0.0013854930473977897
tyrosine,0.0013854930473977897
tumors,0.0013854930473977897
asat,0.0013854930473977897
archived,0.0013854930473977897
auricular,0.0013854930473977897
asthma,0.0013854930473977897
basal,0.0013854930473977897
bacterial,0.0013854930473977897
microg,0.0013854930473977897
meetings,0.0013854930473977897
mn,0.0013854930473977897
mm,0.0013854930473977897
background,0.0013854930473977897
avenue,0.0013854930473977897
availability,0.0013854930473977897
troubles,0.0013854930473977897
tricuspid,0.0013854930473977897
treating,0.0013854930473977897
transthoracic,0.0013854930473977897
lh,0.0013854930473977897
respective,0.0013854930473977897
resources,0.0013854930473977897
lymphoid,0.0013854930473977897
majority,0.0013854930473977897
matching,0.0013854930473977897
transferrin,0.0013854930473977897
bolus,0.0013854930473977897
blockade,0.0013854930473977897
breastfeeding,0.0013854930473977897
carrying,0.0013854930473977897
cd38,0.0013854930473977897
chapter,0.0013854930473977897
cervix,0.0013854930473977897
thanks,0.0013854930473977897
testosterone,0.0013854930473977897
clin,0.0013854930473977897
claude,0.0013854930473977897
commonly,0.0013854930473977897
collections,0.0013854930473977897
lactate,0.0013854930473977897
laboratoire,0.0013854930473977897
rifampicin,0.0013854930473977897
ric,0.0013854930473977897
reticulocyte,0.0013854930473977897
ldh,0.0013854930473977897
ll03,0.0013854930473977897
light,0.0013854930473977897
ligand,0.0013854930473977897
lifestyle,0.0013854930473977897
conclusions,0.0013854930473977897
composed,0.0013854930473977897
tachycardia,0.0013854930473977897
confounding,0.0013854930473977897
confounders,0.0013854930473977897
consultations,0.0013854930473977897
corpuscular,0.0013854930473977897
cord,0.0013854930473977897
investment,0.0013854930473977897
introducing,0.0013854930473977897
intra,0.0013854930473977897
interview,0.0013854930473977897
rnaemia,0.0013854930473977897
joints,0.0013854930473977897
issues,0.0013854930473977897
irradiation,0.0013854930473977897
kinase,0.0013854930473977897
latent,0.0013854930473977897
saliva,0.0013854930473977897
influenza,0.0013854930473977897
insufficiency,0.0013854930473977897
interpreted,0.0013854930473977897
internet,0.0013854930473977897
conversely,0.0013854930473977897
controlling,0.0013854930473977897
switzerland,0.0013854930473977897
sustaining,0.0013854930473977897
susceptible,0.0013854930473977897
countries,0.0013854930473977897
ctfg,0.0013854930473977897
superiority,0.0013854930473977897
suggesting,0.0013854930473977897
suggest,0.0013854930473977897
successive,0.0013854930473977897
successfully,0.0013854930473977897
d7,0.0013854930473977897
d21,0.0013854930473977897
cy,0.0013854930473977897
dedicated,0.0013854930473977897
decisions,0.0013854930473977897
ig,0.0013854930473977897
ib,0.0013854930473977897
secondly,0.0013854930473977897
immunologic,0.0013854930473977897
immuno,0.0013854930473977897
incorporating,0.0013854930473977897
improved,0.0013854930473977897
derivatives,0.0013854930473977897
dependent,0.0013854930473977897
dendritic,0.0013854930473977897
demyelinating,0.0013854930473977897
subgroup,0.0013854930473977897
studied,0.0013854930473977897
strictly,0.0013854930473977897
stratum,0.0013854930473977897
detecting,0.0013854930473977897
greatly,0.0013854930473977897
graall2003,0.0013854930473977897
hbs,0.0013854930473977897
haemoglobin,0.0013854930473977897
hads,0.0013854930473977897
held,0.0013854930473977897
stevens,0.0013854930473977897
dilatation,0.0013854930473977897
distance,0.0013854930473977897
discussed,0.0013854930473977897
donation,0.0013854930473977897
droplet,0.0013854930473977897
dramatically,0.0013854930473977897
efficiency,0.0013854930473977897
futility,0.0013854930473977897
fsh,0.0013854930473977897
shock,0.0013854930473977897
sharing,0.0013854930473977897
shaq,0.0013854930473977897
sf36,0.0013854930473977897
goal,0.0013854930473977897
glucocorticoid,0.0013854930473977897
glomerulonephritis,0.0013854930473977897
globulin,0.0013854930473977897
ss,0.0013854930473977897
squamous,0.0013854930473977897
spot,0.0013854930473977897
sponge,0.0013854930473977897
ema,0.0013854930473977897
enrol,0.0013854930473977897
fewer,0.0013854930473977897
simon,0.0013854930473977897
fluids,0.0013854930473977897
fleming,0.0013854930473977897
frequent,0.0013854930473977897
framework,0.0013854930473977897
eq,0.0013854930473977897
spending,0.0013854930473977897
spc,0.0013854930473977897
exam,0.0013854930473977897
experts,0.0013854930473977897
existing,0.0013854930473977897
excluding,0.0013854930473977897
excipients,0.0013854930473977897
slicc,0.0013854930473977897
sizes,0.0013854930473977897
siti,0.0013854930473977897
extracted,0.0013854930473977897
external,0.0013854930473977897
explore,0.0013854930473977897
female,0.0013854930473977897
finite,0.0013854930473977897
financial,0.0013854930473977897
fields,0.0013854930473977897
quantiferon,0.0013854930473977897
wang,0.0013854930473977897
walk,0.0013854930473977897
1994,0.0013854930473977897
162,0.0013854930473977897
2021,0.0013854930473977897
2020,0.0013854930473977897
37,0.0013854930473977897
36v2,0.0013854930473977897
30g,0.0013854930473977897
program,0.0013854930473977897
process,0.0013854930473977897
randomisation,0.0013854930473977897
proposes,0.0013854930473977897
prolonged,0.0013854930473977897
zero,0.001214772035539342
quantification,0.001214772035539342
proteinuria,0.001214772035539342
psychiatric,0.001214772035539342
virus,0.001214772035539342
fresh,0.001214772035539342
frequently,0.001214772035539342
fraction,0.001214772035539342
equivalent,0.001214772035539342
equal,0.001214772035539342
eq5d,0.001214772035539342
estimation,0.001214772035539342
experienced,0.001214772035539342
experience,0.001214772035539342
excluded,0.001214772035539342
pga,0.001214772035539342
acr,0.001214772035539342
vasopressors,0.001214772035539342
affected,0.001214772035539342
advanced,0.001214772035539342
records,0.001214772035539342
old,0.001214772035539342
oct,0.001214772035539342
osteonecrosis,0.001214772035539342
easily,0.001214772035539342
sri,0.001214772035539342
eltrombopag,0.001214772035539342
enzymes,0.001214772035539342
fever,0.001214772035539342
similarly,0.001214772035539342
similar,0.001214772035539342
fluid,0.001214772035539342
option,0.001214772035539342
adults,0.001214772035539342
v4,0.001214772035539342
air,0.001214772035539342
aminotransferase,0.001214772035539342
american,0.001214772035539342
alternative,0.001214772035539342
necrosis,0.001214772035539342
hormonal,0.001214772035539342
details,0.001214772035539342
despite,0.001214772035539342
diagnostic,0.001214772035539342
distribution,0.001214772035539342
drop,0.001214772035539342
functional,0.001214772035539342
gold,0.001214772035539342
glomerular,0.001214772035539342
newly,0.001214772035539342
alt,0.001214772035539342
undergoing,0.001214772035539342
angiography,0.001214772035539342
analyze,0.001214772035539342
anxiety,0.001214772035539342
approximately,0.001214772035539342
minimal,0.001214772035539342
molecular,0.001214772035539342
improve,0.001214772035539342
degree,0.001214772035539342
subpopulation,0.001214772035539342
strategy,0.001214772035539342
development,0.001214772035539342
growth,0.001214772035539342
sequentially,0.001214772035539342
ms,0.001214772035539342
monotherapy,0.001214772035539342
nasal,0.001214772035539342
myocarditis,0.001214772035539342
murine,0.001214772035539342
nephropathy,0.001214772035539342
apn,0.001214772035539342
uln,0.001214772035539342
atrial,0.001214772035539342
ast,0.001214772035539342
requirements,0.001214772035539342
microalbuminuria,0.001214772035539342
metastatic,0.001214772035539342
metabolic,0.001214772035539342
criss,0.001214772035539342
creatininuria,0.001214772035539342
cyclosporine,0.001214772035539342
decided,0.001214772035539342
sclerosis,0.001214772035539342
immunosuppressants,0.001214772035539342
immunosuppressant,0.001214772035539342
immunomodulatory,0.001214772035539342
indicating,0.001214772035539342
independently,0.001214772035539342
inhibition,0.001214772035539342
inferiority,0.001214772035539342
initiated,0.001214772035539342
interventional,0.001214772035539342
interferon,0.001214772035539342
involve,0.001214772035539342
contraindication,0.001214772035539342
survey,0.001214772035539342
mmf,0.001214772035539342
minor,0.001214772035539342
minimum,0.001214772035539342
autoantibodies,0.001214772035539342
authorized,0.001214772035539342
authorization,0.001214772035539342
base,0.001214772035539342
biology,0.001214772035539342
binomial,0.001214772035539342
responding,0.001214772035539342
tarte,0.001214772035539342
consider,0.001214772035539342
room,0.001214772035539342
rodnan,0.001214772035539342
ktr,0.001214772035539342
longer,0.001214772035539342
maintenance,0.001214772035539342
mainly,0.001214772035539342
match,0.001214772035539342
medullar,0.001214772035539342
bilag,0.001214772035539342
block,0.001214772035539342
ch50,0.001214772035539342
chose,0.001214772035539342
chorioretinal,0.001214772035539342
complement,0.001214772035539342
comorbidity,0.001214772035539342
legal,0.001214772035539342
lead,0.001214772035539342
limit,0.001214772035539342
c4,0.001214772035539342
c3,0.001214772035539342
brochure,0.001214772035539342
thymocyte,0.001214772035539342
threshold,0.001214772035539342
cd8,0.001214772035539342
characterize,0.001214772035539342
publique,0.001214772035539342
vs,0.001214772035539342
61,0.001214772035539342
5l,0.001214772035539342
reaches,0.001214772035539342
phrc,0.001214772035539342
priapism,0.001214772035539342
prevention,0.001214772035539342
prevent,0.001214772035539342
explored,0.001214772035539342
2011,0.001214772035539342
250,0.001214772035539342
2015,0.001214772035539342
49,0.001214772035539342
profiles,0.001214772035539342
random,0.001214772035539342
radiological,0.001214772035539342
questionnaires,0.001214772035539342
question,0.001214772035539342
prospectively,0.001214772035539342
aa,0.0010752828122292649
65,0.0010752828122292649
sledai,0.0010752828122292649
person,0.0010752828122292649
judgment,0.0010752828122292649
infarct,0.0010752828122292649
candidate,0.0010752828122292649
class,0.0010752828122292649
bleeding,0.0010752828122292649
laherparepvec,0.0010752828122292649
combined,0.0010752828122292649
qol,0.0010752828122292649
ventilation,0.0010752828122292649
achieved,0.0010752828122292649
account,0.0010752828122292649
pathology,0.0010752828122292649
pan,0.0010752828122292649
phenotypic,0.0010752828122292649
correlated,0.0010752828122292649
malignant,0.0010752828122292649
m6,0.0010752828122292649
binding,0.0010752828122292649
meeting,0.0010752828122292649
tomography,0.0010752828122292649
tolerated,0.0010752828122292649
bmt,0.0010752828122292649
cerebral,0.0010752828122292649
institut,0.0010752828122292649
immunological,0.0010752828122292649
hypothesis,0.0010752828122292649
define,0.0010752828122292649
damage,0.0010752828122292649
cytokines,0.0010752828122292649
mismatch,0.0010752828122292649
mmol,0.0010752828122292649
beginning,0.0010752828122292649
biomarkers,0.0010752828122292649
like,0.0010752828122292649
computed,0.0010752828122292649
talimogene,0.0010752828122292649
taking,0.0010752828122292649
consecutive,0.0010752828122292649
context,0.0010752828122292649
selena,0.0010752828122292649
hematological,0.0010752828122292649
mechanical,0.0010752828122292649
cure,0.0010752828122292649
criterion,0.0010752828122292649
erythrocyte,0.0010752828122292649
evaluate,0.0010752828122292649
activation,0.0010752828122292649
formula,0.0010752828122292649
estimated,0.0010752828122292649
fludarabine,0.0010752828122292649
virological,0.0010752828122292649
recommendation,0.0010752828122292649
usually,0.0010752828122292649
allograft,0.0010752828122292649
standardization,0.0010752828122292649
nei,0.0010752828122292649
needs,0.0010752828122292649
regression,0.0010752828122292649
note,0.0010752828122292649
elderly,0.0010752828122292649
silent,0.0010752828122292649
functions,0.0010752828122292649
future,0.0010752828122292649
answer,0.0010752828122292649
nomenclature,0.0010752828122292649
moderate,0.0010752828122292649
models,0.0010752828122292649
depression,0.0010752828122292649
stroke,0.0010752828122292649
deterioration,0.0010752828122292649
gr,0.0010752828122292649
ref,0.0010752828122292649
aged,0.0010752828122292649
global,0.0010752828122292649
estimate,0.0010752828122292649
effective,0.0010752828122292649
2016,0.0009573463543581594
2014,0.0009573463543581594
proportion,0.0009573463543581594
presented,0.0009573463543581594
able,0.0009573463543581594
plan,0.0009573463543581594
family,0.0009573463543581594
costs,0.0009573463543581594
mixed,0.0009573463543581594
biopsies,0.0009573463543581594
measure,0.0009573463543581594
cause,0.0009573463543581594
therapies,0.0009573463543581594
chamber,0.0009573463543581594
classic,0.0009573463543581594
thrombosis,0.0009573463543581594
calculated,0.0009573463543581594
limited,0.0009573463543581594
therapeutic,0.0009573463543581594
transfusion,0.0009573463543581594
low,0.0009573463543581594
iron,0.0009573463543581594
terms,0.0009573463543581594
isatuximab,0.0009573463543581594
cov2,0.0009573463543581594
surgery,0.0009573463543581594
haze,0.0009573463543581594
neutrophils,0.0009573463543581594
normal,0.0009573463543581594
percentage,0.0009573463543581594
performance,0.0009573463543581594
neurological,0.0009573463543581594
effect,0.0009573463543581594
icu,0.0009573463543581594
opinion,0.0009573463543581594
hospitalizations,0.0009573463543581594
overload,0.0009573463543581594
start,0.0009573463543581594
antibiotics,0.0009573463543581594
historical,0.0009573463543581594
engraftment,0.0009573463543581594
rates,0.0008551851476844063
prca,0.0008551851476844063
hematopoietic,0.0008551851476844063
interval,0.0008551851476844063
survival,0.0008551851476844063
vitreous,0.0008551851476844063
cardiac,0.0008551851476844063
chronic,0.0008551851476844063
anterior,0.0008551851476844063
includes,0.0008551851476844063
edema,0.0008551851476844063
unrelated,0.0008551851476844063
steroids,0.0008551851476844063
step,0.0008551851476844063
validated,0.0008551851476844063
adapted,0.0008551851476844063
overall,0.0008551851476844063
vessel,0.0008551851476844063
